STAT3 and breast benign neoplasm: Existing studies have confirmed that the IL-6/JAK/STAT3 signaling pathway is crucial for the proliferation and survival of tumor cells (9); however, it is unclear whether this pathway plays a similar role in GLM formation and whether its mechanism is similar to that in benign breast tumor.